Memantine for the patients with mild cognitive impairment in parkinson’s disease: a pharmacological fmri study

HIGHLIGHTS

  • who: Shoji Kawashima from the Department of Neurology and Neuroscience, Nagoya City University Nagoya, u20118601, Japan have published the research work: Memantine for the patients with mild cognitive impairment in Parkinsonu2019s disease: a pharmacological fMRI study, in the Journal: (JOURNAL)
  • what: The authors aimed to investigate whether memantine can alter brain function of the patients with PD-MCI, using fMRI. The n-back test used in this study is a modified version of visuospatial n-back test which was reported in fMRI studies for normal subjects . The deactivation of the LG in this study may . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?